STOCK TITAN

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

111, Inc. (NASDAQ: YI) will release its unaudited financial results for Q1 2024 on May 23, 2024. The company aims to digitally connect patients with medicine and healthcare services in China. The earnings conference call will take place at 7:30 AM U.S. Eastern Time on the same day.

111, Inc. (NASDAQ: YI) pubblicherà i suoi risultati finanziari non revisionati per il primo trimestre del 2024 il 23 maggio 2024. L'obiettivo dell'azienda è quello di connettere digitalmente i pazienti con i medicinali e i servizi sanitari in Cina. La teleconferenza sui risultati si terrà alle 7:30 AM ora orientale degli Stati Uniti, nello stesso giorno.
111, Inc. (NASDAQ: YI) publicará sus resultados financieros no auditados para el primer trimestre de 2024 el 23 de mayo de 2024. La empresa tiene como objetivo conectar digitalmente a los pacientes con medicamentos y servicios de salud en China. La conferencia de resultados se realizará a las 7:30 AM, hora del este de EE. UU., el mismo día.
111, Inc. (나스닥: YI)는 2024년 5월 23일에 2024년 1분기에 대한 감사되지 않은 재무 결과를 발표할 것입니다. 이 회사는 중국에서 환자들을 의약품 및 보건 서비스와 디지털로 연결하는 것을 목표로 하고 있습니다. 수익 관련 전화 회의는 같은 날 미국 동부 시간으로 오전 7시 30분에 진행될 예정입니다.
111, Inc. (NASDAQ: YI) va publier ses résultats financiers non audités pour le premier trimestre de 2024 le 23 mai 2024. La société a pour objectif de connecter numériquement les patients avec les médicaments et les services de santé en Chine. La conférence téléphonique sur les résultats aura lieu à 7h30, heure de l'Est des États-Unis, le même jour.
111, Inc. (NASDAQ: YI) wird seine ungeprüften Finanzergebnisse für das erste Quartal 2024 am 23. Mai 2024 veröffentlichen. Das Unternehmen zielt darauf ab, Patienten in China digital mit Medikamenten und Gesundheitsdiensten zu verbinden. Die Telefonkonferenz zu den Ergebnissen findet am selben Tag um 7:30 Uhr US-Ostküstenzeit statt.
Positive
  • None.
Negative
  • None.

SHANGHAI, April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024, before the U.S. market opens on Thursday, May 23, 2024.

111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, May 23, 2024 (7:30 PM Beijing Time on the same day).

Details for the conference call are as follows:

Conference Topic: 111, Inc. First Quarter 2024 Earnings Conference Call
Registration Link: https://s1.c-conf.com/diamondpass/10038645-oelc5s.html

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will then be provided with the dial in number, the Passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

Please dial in 15 minutes before the call is scheduled to begin. To join the conference, simply dial the number in the calendar invite and enter the passcode followed by your PIN, and you will join the conference instantly.

A live and archived webcast of the conference call will be available on the website at https://edge.media-server.com/mmc/p/83ojreww.

A telephone replay of the call will be available after the conclusion of the conference call until May 30, 2024.

China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10038645

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

Cision View original content:https://www.prnewswire.com/news-releases/111-to-announce-first-quarter-2024-unaudited-financial-results-on-may-23-2024---conference-call-to-follow-302131113.html

SOURCE 111, Inc.

FAQ

When will 111, Inc. announce its Q1 2024 unaudited financial results?

111, Inc. will release its unaudited financial results for Q1 2024 on May 23, 2024.

What is the focus of 111, Inc.?

111, Inc. is focused on digitally connecting patients with medicine and healthcare services in China.

When is the earnings conference call scheduled?

The earnings conference call is scheduled for 7:30 AM U.S. Eastern Time on May 23, 2024.

Where can participants register for the conference call?

Participants can register for the conference call using the following link: https://s1.c-conf.com/diamondpass/10038645-oelc5s.html

Will there be a webcast of the conference call?

Yes, a live and archived webcast of the conference call will be available on the website at https://edge.media-server.com/mmc/p/83ojreww.

111, Inc.

NASDAQ:YI

YI Rankings

YI Latest News

YI Stock Data

112.55M
65.94M
16.72%
28.28%
0.04%
Pharmacies and Drug Stores
Retail Trade
Link
United States of America
Shanghai

About YI

111, inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the people's republic of china. it operates through two segments, b2b and b2c. the company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. its product portfolio comprises prescription and over-the counter drugs, such as western and traditional chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. the company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 drug mall, includin